Aspirin as a Treatment for ARDS-Reference-Cited by-同舟云学术

Aspirin as a Treatment for ARDS

Published:2021-11 Issue: Volume: Page:
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Toner Philip,Boyle Andrew J.,McNamee James J.,Callaghan Kathryn,Nutt Christopher,Johnston Paul,Trinder John,McFarland Margaret,Verghis Rejina,McAuley Daniel F.,O’Kane Cecilia M.

Funder

Public Health Agency

Department for Employment and Learning, Northern Ireland

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference39 articles.

1. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries;Bellani;JAMA,2016

2. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome;Cheung;Am J Respir Crit Care Med,2006

3. Pharmacological treatments in ARDS: a state-of-the-art update;Boyle;BMC Med,2013

4. Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome;Toner;Crit Care,2015

5. Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk;Wei;Chest,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of antiplatelet agents with mortality among patients with non–COVID-19 community-acquired pneumonia: a systematic review and meta-analysis;Research and Practice in Thrombosis and Haemostasis;2024-07

2. Research progress of megakaryocytes and platelets in lung injury;Annals of Medicine;2024-06-20

3. An update on the pharmacological management of acute respiratory distress syndrome;Expert Opinion on Pharmacotherapy;2024-06-12

4. Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study;Pulmonary Pharmacology & Therapeutics;2024-06

5. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS);International Journal of Pharmaceutics;2024-05